Nontuberculous Mycobacterial Infection Global Market Report 2024

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	175 Pages	The Business Research Company	January, 2024	BRC18450615

Best Price Guarantee
Price	from $5,000
Length	175 Pages
Publisher	The Business Research Company
Published Date	January, 2024
SKU	BRC18450615

Nontuberculous Mycobacterial Infection Global Market Report 2024

Including: 1) By Drug Class: Macrolides; Rifampin; Aminoglycoside2) By Route Of Administration: Oral; Parenteral3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffman La Roche AG; Merck & Co. Inc.; AbbVie Inc.

Nontuberculous Mycobacterial Infection Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nontuberculous mycobacterial infection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for nontuberculous mycobacterial infection? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nontuberculous mycobacterial infection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Drug Class: Macrolides; Rifampin; Aminoglycoside; Other Drug Classes

2) By Route Of Administration: Oral; Parenteral; Other Routes

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffman La Roche AG; Merck & Co. Inc.; AbbVie Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Nontuberculous Mycobacterial Infection Market Characteristics
3. Nontuberculous Mycobacterial Infection Market Trends And Strategies
4. Nontuberculous Mycobacterial Infection Market - Macro Economic Scenario: 4.1. Impact Of High Inflation On The Market; 4.2. Ukraine-Russia War Impact On The Market; 4.3. COVID-19 Impact On The Market
5. Global Nontuberculous Mycobacterial Infection Market Size and Growth: 5.1. Global Nontuberculous Mycobacterial Infection Market Drivers and Restraints; 5.1.1. Drivers Of The Market; 5.1.2. Restraints Of The Market; 5.2. Global Nontuberculous Mycobacterial Infection Historic Market Size and Growth, 2018 - 2023, Value ($ Billion); 5.3. Global Nontuberculous Mycobacterial Infection Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Nontuberculous Mycobacterial Infection Market Segmentation: 6.1. Global Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Macrolides; Rifampin; Aminoglycoside; Other Drug Classes; 6.2. Global Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Oral; Parenteral; Other Routes; 6.3. Global Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
7. Nontuberculous Mycobacterial Infection Market Regional And Country Analysis: 7.1. Global Nontuberculous Mycobacterial Infection Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 7.2. Global Nontuberculous Mycobacterial Infection Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Nontuberculous Mycobacterial Infection Market: 8.1. Asia-Pacific Nontuberculous Mycobacterial Infection Market Overview; Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 8.3. Asia-Pacific Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 8.4. Asia-Pacific Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Nontuberculous Mycobacterial Infection Market: 9.1. China Nontuberculous Mycobacterial Infection Market Overview; 9.2. China Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion; 9.3. China Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion; 9.4. China Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Nontuberculous Mycobacterial Infection Market: 10.1. India Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 10.2. India Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 10.3. India Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Nontuberculous Mycobacterial Infection Market: 11.1. Japan Nontuberculous Mycobacterial Infection Market Overview; 11.2. Japan Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 11.3. Japan Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 11.4. Japan Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Nontuberculous Mycobacterial Infection Market: 12.1. Australia Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 12.2. Australia Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 12.3. Australia Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Nontuberculous Mycobacterial Infection Market: 13.1. Indonesia Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 13.2. Indonesia Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 13.3. Indonesia Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Nontuberculous Mycobacterial Infection Market: 14.1. South Korea Nontuberculous Mycobacterial Infection Market Overview; 14.2. South Korea Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 14.3. South Korea Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 14.4. South Korea Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Nontuberculous Mycobacterial Infection Market: 15.1. Western Europe Nontuberculous Mycobacterial Infection Market Overview; 15.2. Western Europe Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 15.3. Western Europe Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 15.4. Western Europe Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Nontuberculous Mycobacterial Infection Market: 16.1. UK Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 16.2. UK Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 16.3. UK Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Nontuberculous Mycobacterial Infection Market: 17.1. Germany Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 17.2. Germany Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 17.3. Germany Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Nontuberculous Mycobacterial Infection Market: 18.1. France Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 18.2. France Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 18.3. France Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Nontuberculous Mycobacterial Infection Market: 19.1. Italy Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 19.2. Italy Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 19.3. Italy Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Nontuberculous Mycobacterial Infection Market: 20.1. Spain Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 20.2. Spain Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 20.3. Spain Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Nontuberculous Mycobacterial Infection Market: 21.1. Eastern Europe Nontuberculous Mycobacterial Infection Market Overview; 21.2. Eastern Europe Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 21.3. Eastern Europe Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 21.4. Eastern Europe Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Nontuberculous Mycobacterial Infection Market: 22.1. Russia Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 22.2. Russia Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 22.3. Russia Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Nontuberculous Mycobacterial Infection Market: 23.1. North America Nontuberculous Mycobacterial Infection Market Overview; 23.2. North America Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 23.3. North America Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 23.4. North America Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Nontuberculous Mycobacterial Infection Market: 24.1. USA Nontuberculous Mycobacterial Infection Market Overview; 24.2. USA Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 24.3. USA Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 24.4. USA Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Nontuberculous Mycobacterial Infection Market: 25.1. Canada Nontuberculous Mycobacterial Infection Market Overview; 25.2. Canada Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 25.3. Canada Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 25.4. Canada Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Nontuberculous Mycobacterial Infection Market: 26.1. South America Nontuberculous Mycobacterial Infection Market Overview; 26.2. South America Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 26.3. South America Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 26.4. South America Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Nontuberculous Mycobacterial Infection Market: 27.1. Brazil Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 27.2. Brazil Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 27.3. Brazil Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Nontuberculous Mycobacterial Infection Market: 28.1. Middle East Nontuberculous Mycobacterial Infection Market Overview; 28.2. Middle East Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 28.3. Middle East Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 28.4. Middle East Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Nontuberculous Mycobacterial Infection Market: 29.1. Africa Nontuberculous Mycobacterial Infection Market Overview; 29.2. Africa Nontuberculous Mycobacterial Infection Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 29.3. Africa Nontuberculous Mycobacterial Infection Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 29.4. Africa Nontuberculous Mycobacterial Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Nontuberculous Mycobacterial Infection Market Competitive Landscape And Company Profiles: 30.1. Nontuberculous Mycobacterial Infection Market Competitive Landscape; 30.2. Nontuberculous Mycobacterial Infection Market Company Profiles; 30.2.1. Pfizer Inc.; 30.2.1.1. Overview; 30.2.1.2. Products and Services; 30.2.1.3. Strategy; 30.2.1.4. Financial Performance; 30.2.2. Johnson & Johnson; 30.2.2.1. Overview; 30.2.2.2. Products and Services; 30.2.2.3. Strategy; 30.2.2.4. Financial Performance; 30.2.3. F. Hoffman La Roche AG; 30.2.3.1. Overview; 30.2.3.2. Products and Services; 30.2.3.3. Strategy; 30.2.3.4. Financial Performance; 30.2.4. Merck & Co. Inc.; 30.2.4.1. Overview; 30.2.4.2. Products and Services; 30.2.4.3. Strategy; 30.2.4.4. Financial Performance; 30.2.5. AbbVie Inc.; 30.2.5.1. Overview; 30.2.5.2. Products and Services; 30.2.5.3. Strategy; 30.2.5.4. Financial Performance
31. Nontuberculous Mycobacterial Infection Market Other Major And Innovative Companies: 31.1. Bayer AG; 31.2. Novartis AG; 31.3. Sanofi S.A.; 31.4. Bristol Myers Squibb; 31.5. AstraZeneca plc; 31.6. Abbott Laboratories; 31.7. GlaxoSmithKline plc; 31.8. Takeda Pharmaceutical Company; 31.9. Eli Lilly and Company; 31.10. C.H. Boehringer Sohn AG & Co. KG; 31.11. Teva Pharmaceutical Industries Ltd.; 31.12. Mylan N.V.; 31.13. Astellas Pharma Inc.; 31.14. Vertex Pharmaceuticals Inc.; 31.15. Sun Pharmaceutical Industries Ltd.
32. Global Nontuberculous Mycobacterial Infection Market Competitive Benchmarking
33. Global Nontuberculous Mycobacterial Infection Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Nontuberculous Mycobacterial Infection Market
35. Nontuberculous Mycobacterial Infection Market Future Outlook and Potential Analysis: 35.1 Nontuberculous Mycobacterial Infection Market In 2028 - Countries Offering Most New Opportunities; 35.2 Nontuberculous Mycobacterial Infection Market In 2028 - Segments Offering Most New Opportunities; 35.3 Nontuberculous Mycobacterial Infection Market In 2028 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer